Intermolecular, Inc. (IMI) Upgraded by ValuEngine to Sell

Intermolecular, Inc. (NASDAQ:IMI) was upgraded by investment analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research note issued to investors on Monday, August 7th.

Shares of Intermolecular (IMI) traded up 1.868% during midday trading on Monday, hitting $0.927. 37,430 shares of the company’s stock traded hands. The stock’s market cap is $45.94 million. The company has a 50 day moving average of $0.95 and a 200 day moving average of $0.94. Intermolecular has a 52 week low of $0.78 and a 52 week high of $1.21.

TRADEMARK VIOLATION NOTICE: This report was first posted by BNB Daily and is owned by of BNB Daily. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at

In other Intermolecular news, major shareholder Lloyd I. Miller III purchased 80,000 shares of the firm’s stock in a transaction dated Thursday, June 22nd. The stock was bought at an average price of $0.88 per share, with a total value of $70,400.00. Following the completion of the purchase, the insider now owns 70,368 shares in the company, valued at approximately $61,923.84. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In the last three months, insiders bought 121,376 shares of company stock valued at $105,636. Company insiders own 15.20% of the company’s stock.

An institutional investor recently raised its position in Intermolecular stock. Renaissance Technologies LLC boosted its stake in shares of Intermolecular, Inc. (NASDAQ:IMI) by 0.6% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 831,499 shares of the semiconductor company’s stock after buying an additional 4,633 shares during the period. Renaissance Technologies LLC owned 1.68% of Intermolecular worth $773,000 as of its most recent SEC filing. 38.87% of the stock is currently owned by institutional investors.

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply